Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
European Journal of Haematology|April 21, 2015
A prospective, multicenter phase II study of continuous infusion of FLAG for patients older than 60 yr with resistant acute myeloid leukemia: a comparison with intensive younger patients' trialHawk Kim, Je-Hwan Lee, Young-Don Joo, et al.
Acta Haematologica|July 14, 2016
Comparable Allogeneic Hematopoietic Cell Transplantation Outcome of a Haplo-Identical Family Donor with an Alternative Donor in Adult Aplastic AnemiaHawk Kim, Je-Hwan Lee, Young-Don Joo, et al.
Acta Haematologica|February 12, 2014
Prospective, multicenter, phase II study on reducing the dosage of idarubicin and FLAG for patients younger than 65 years with resistant acute myeloid leukemia: a comparison with a higher dosage trialHawk Kim, Je-Hwan Lee, Young-Don Joo, et al.
Therapeutic Advances in Hematology|November 6, 2023
Effect of <i>BCR::ABL1</i> transcript type and droplet digital polymerase chain reaction on successful treatment-free remission in chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitorHyunkyung Park, Hyeong-Joon Kim, Sang-Kyun Sohn, et al.
Annals of Hematology|July 31, 2025
Gene expression analysis of patients with chronic myeloid leukemia who discontinued tyrosine kinase inhibitorHyunkyung Park, Hyeong-Joon Kim, Sang-Kyun Sohn, et al.
Annals of Hematology|October 21, 2010
Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemmaSeok Jin Kim, Sung Yong Oh, Jin Seok Kim, et al.
The American Journal of Case Reports|July 26, 2016
Angioimmunoblastic T-Cell Lymphoma in a Patient with Klinefelter SyndromeYong Tae Park, Chan-Ho Park, Mi Ae Bae, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 8, 2018
Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic-Phase Chronic Myeloid LeukemiaHawk Kim, SooHyun Kim, Hyeoung-Joon Kim, et al.
Annals of Hematology|April 25, 2012
A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndromeHawk Kim, Je-Hwan Lee, Young-Don Joo, et al.
Leukemia Research|August 22, 2017
Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series studyJe-Hwan Lee, Yoo-Jin Kim, Sang Kyun Sohn, et al.
Pageof 12